CDSCO UID IMP/IVD/2020/000615_fd27a76e6e3a9070b9a263cfd7eaa909_63749530d4db78c6293912db76b54177HemosIL Direct Thrombin Inhibitor Assay
- UID
- IMP/IVD/2020/000615_fd27a76e6e3a9070b9a263cfd7eaa909_63749530d4db78c6293912db76b54177
- Device class
- Class C
- Brand name
- HemosIL
- License holder
- Instrumentation Laboratory India Pvt Ltd
- Approving authority
- CDSCO
- Product information
- The HemosIL Direct Thrombin Inhibitor (HemosIL) Assay is an in vitro diagnostic assay for the quantitative determination of the Direct Thrombin Inhibitor Dabigatran in citrated human plasma on the ACL TOP Family of analyzers. The product is intended to be used for the measurement of active Dabigatran levels in situations where measurement is warranted
HemosIL Direct Thrombin Inhibitor Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000615_fd27a76e6e3a9070b9a263cfd7eaa909_63749530d4db78c6293912db76b54177. This device is marketed under the brand name HemosIL. The license holder is Instrumentation Laboratory India Pvt Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.